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5.1 Introduction 
 
Stein and Leventhal’s finding of polycystic ovaries, which they eponymously 
described as part of a circumscribed clinical syndrome [1], has evolved to become a 
nebulous entity with polycystic ovaries as a prominent component. Biochemical 
aspects, both endocrine and non-endocrine, have become part of a wider “polycystic 
ovary syndrome” (PCOS), recognised as a very common cause of anovulatory 
infertility [2 – 4]. Whilst the original Stein-Leventhal Syndrome described multiple 
ovarian cysts, obesity, hirsutism, menstrual abnormalities and amenorrhoea, 
symptoms of PCOS also include acne and androgenic alopecia. Obesity, when it 
occurs, tends to include centrally-distributed adipose tissue. These features, singly or 
together, are not evident in all affected women [5]. Despite this, most show a degree 
of insulin resistance [6]. PCOS is thus a complex endocrine disorder, for which the 
diagnosis is not always straightforward [6, 7]. However, many practitioners now agree 
that it can be defined on the basis of at least two of the following features in 
combination: presence of polycystic ovaries on ultrasound examination; oligo-
/anovulation; clinical or biochemical evidence of androgen excess [5]. 
 
In PCOS, interference with the pituitary ovarian axis results in over-recruitment of 
follicles to a size of about 5mm, with no subsequent selection and maturation of a 
single ‘leading’ follicle. The resultant cohort of many 5mm follicles align themselves 
under the surface of the ovary but the oocytes never mature and erupt. Ovulation does 
not occur; luteinizing hormone (LH) remains elevated but never surges. Polycystic 
ovaries overproduce androgens, although some of the excess androgens observed in 
women with polycystic ovaries could be adrenal in origin [6]. Elevated androgen 
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levels in women may lead to hirsutism and menstrual irregularities [8]. High levels of 
androgens also appear to be related to increased risk of cardiovascular disease, high 
insulin levels, and Type 2 diabetes [9, 10]. In addition, hyperinsulinaemia can act to 
further stimulate ovarian androgen production, resulting in an interaction effect 
between hyperandrogenism and hyperinsulinaemia [8], although there is no evidence 
of a similar effect on adrenal androgens [11]. Obesity, observed in a large proportion 
of women with polycystic ovaries, exacerbates these endocrine disturbances. Weight 
loss can lead to a reduction in insulin resistance and an improvement in endocrine 
status that often results in resumption of ovulation [6]. In clinical practice, women 
with PCOS seeking fertility treatment are frequently advised that weight loss is the 
first avenue that should be explored [12, 13].   
 
5.2 Prevalence Of Polycystic Ovaries And PCOS And Phenotypic Differences In 
The Expression Of Associated Traits 
 
The presence of polycystic ovaries does not automatically imply the presence of the 
associated syndrome. Based on studies conducted in the UK and Australasia, 
polycystic ovaries themselves (but not necessaily PCOS) are found in over a fifth of 
females (see review by [5]), and do not necessarily result in diminished fertility [14]. 
In some populations the prevalence of polycystic ovaries has been observed to be 
much higher than one in five, with the highest recorded to date, over half, being in 
randomly-selected South Asians living in the UK [15]. Some non-randomly selected 
samples also show inter-population differences. Polycystic ovaries were observed in 
45% of Yoruba women from western Nigeria attending a UK fertility clinic, in 
contrast to 11% in the infertile European women studied [16]. However, other studies 
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examining the prevalence of polycystic ovaries in women seeking fertility treatment 
recorded no differences between ethnic groups [17].   
 
Based on UK and Australasian studies, around 1 in 12 females have polycystic ovary 
syndrome [5]. Although differential diagnosis of PCOS hampers rigorous inter-
population comparisons, a body of evidence is accumulating that suggests variations 
in the prevalence of the syndrome exist across different cultural or geographic 
populations [4, 18 - 20; see also Table 1]. In the U.K., there appears to be a higher 
prevalence of PCOS in British South Asian women than in their European 
counterparts [4].  This is also the case in New Zealand, where Indian women with 
PCOS are over-represented compared to the general population [19]. An increased 
prevalence in Caribbean Hispanic and Mexican American women [21, 22], as well as 
in Aboriginal Australians [20], has also been suggested. In contrast, one study has 
found that Chinese women with PCOS living in New Zealand were under-represented 
compared to the population as a whole [19].  
 
TABLE 1 HERE 
 
Population-based phenotypic differences in the expression of traits associated with 
PCOS have also been observed. One study of women with PCOS from different 
populations (Japanese, Italian and U.S.) indicated that although adrenal androgen 
excess and insulin resistance appeared to be at similar levels in all three populations, 
levels of obesity and hirsutism showed considerable interpopulation variation [23]. 
This is probably related to proximate environmental influences as well as the 
biological variation observed in the general populations from which these women 
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came [23], with people from Japan, for example, being on the whole less hirsute than 
those from the Mediterranean. In some cross-population studies, however, significant 
endocrine differences have been observed. Mexican American women with PCOS are 
more insulin resistant and show higher incidences of insulin resistance than their 
European counterparts [24], as well as having lower circulating levels of 
dehydroepiandrosterone sulphate (DHEAS), an indicator of adrenal androgen 
production [11]. European women from Iceland have higher androstenedione, lower 
testosterone, less acne and are less hirsute than European women with PCOS from 
Boston, U.S. [25]. British South Asian women have higher fasting insulin 
concentrations, lower insulin sensitivity and exhibit more severe symptoms of PCOS 
than do UK European women [4]. Middle Eastern women with PCOS also have 
higher insulin levels than Western European women, independent of age and BMI 
[26]. In New Zealand, Maori and Pacific Island women with PCOS are most likely to 
be overweight and have the highest rates of insulin resistance [19].  
 
5.3 Genetic And Developmental Predispositions To PCOS 
 
PCOS is very likely to have a genetic basis, as it appears to run in families  [27, 28] 
and there is greater concordance of PCOS-related traits in monozygotic than in 
dizygotic twins [29], although some of the evidence from twin studies is equivocal 
[30]. However, interpopulation differences in prevalence and phenotypic expression 
of PCOS also lend support to the notion that PCOS has a genetic component. 
Nonetheless, identifying specific genes is proving to be far from straightforward [28]. 
The association between the calpain-10 gene, insulin resistance and Type 2 diabetes 
led to research into whether it also has a link to PCOS [31, 32], but the results to date 
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have been inconclusive. One relatively small study identified an association between 
the calpain-10 112/121-haplotype combination and an increased risk (based on odds 
ratios) of PCOS in African Americans and Europeans [31]. A second, slightly larger, 
study found no robust association between the calpain-10 gene and PCOS [32]. Much 
larger studies might be required to detect clear links, if they exist, between the two 
[32]. However, the Pro
12
Ala polymorphism in the PPARγ gene might have a role in 
modifying the insulin resistance of European women with PCOS, as those with the 
Pro/Ala genotype appear to have increased insulin sensitivity compared to those with 
the Pro/Pro genotype [33]. However, this finding does not extend to African 
American women [33]. Polymorphisms of the insulin receptor substrate-1 (IRS-1) 
gene appear to be associated with the phenotypic expression of PCOS in some 
populations [34] including Europeans [35], but not  Taiwanese women [36]. However, 
there is strong evidence for a PCOS susceptibility locus that maps close to the 
D19S884 dinucleotide repeat marker, linked to the insulin receptor gene on 
chromosome 19p13.2 [37]. On current evidence, therefore, it is likely that a small 
number of genes involved in regulating steroid biosynthesis and glucose homeostasis 
contribute to PCOS [27], although a great deal of work still remains to be done in 
identifying candidate genes [28].        
 
There is also likely to be a strong developmental component to PCOS. Females with 
low birthweight apparently have greater chance of precocious pubarche, a risk factor 
for PCOS, and also the development of hyperinsulinaemia and hyperandrogenism 
[38], although a subsequent study on a larger cohort did not support this finding [39]. 
Comparison of South Asian and European women born and resident in the UK with 
South Asian women who live in the UK but were born in Pakistan suggests that the 
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relatively poor early environment experienced by first generation Pakistani 
immigrants to the UK is an important contributory factor in the relatively high levels 
of free androgens observed in these women [10]. Low birthweight has also been 
highlighted as an important precursor of dyslipidaemia and insulin resistance later in 
life [e.g. 40 – 42]. One hypothesis is that poor fetal and infant growth can promote the 
development of PCOS in individuals with a genetic susceptibility, especially when 
exposed to a nutritional environment of ‘excess’ later in life. It is also possible that 
exposure to excess androgens during development plays a central role in the 
development of PCOS [28]. Prenatally androgenized animal models (sheep and rhesus 
macaques) display many of the traits associated with PCOS in humans [43, 44]. In 
humans, exposure to excess androgens, possibly as a result of the action of genes that 
regulate the relevant pathways, might occur during the short-lived activation of the 
hypothalamic-pituitary-gonadal axis in infancy as well as at puberty [28]. This in turn 
might lead to endocrine disturbance, including insulin resistance and elevated LH, and 
abdominal adiposity, the effects of which can be mediated or magnified by diet [28].   
 
5.4 Evolutionary Perspective On PCOS: Seasonality And Unpredictable 
Environments 
 
The strong role that genetic factors apparently play in PCOS plus its high general 
prevalence worldwide could indicate an evolutionary basis to the syndrome. In other 
words, at some point in our evolutionary history, PCOS might have been selectively 
advantageous, resulting in the high levels observed today. A number of authors have 
argued along these lines, particularly in terms of the ‘thrifty genotype’ [7, 45 – 47]. It 
is hypothesized that women with PCOS who have a high chance of being obese and 
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anovulatory during times of normal or excess food availability, and who begin to 
ovulate on weight loss, have a selective advantage by being able to reproduce during 
periods of food shortage, when other women become anovulatory [7, 46]. When faced 
with a modern Westernised lifestyle characterised by abundant food and limited 
physical activity, however, the ‘thrifty genes’ that might have been advantageous 
under certain environmental conditions contribute to PCOS and become 
disadvantageous [45].    
 
A similar argument has been played out for another condition of insulin resistance, 
type 2 diabetes. It has been suggested that modern populations, specifically the Pima 
and some Pacific island groups, with high levels of insulin resistance were at some 
point in the past subjected to environments with extremely poor food availability, 
possibly with feast/famine cycles [48, 49]. As with PCOS, genes that today 
predispose individuals to insulin resistance could have therefore conferred a selective 
advantage for survival, but in times of relative abundance, they cease to do this and 
instead result in serious health problems [48]. Long periods of food shortage during 
the colonizations of the Americas and Pacific have been suggested as the primary 
selective agent for such a ‘thrifty genotype’ in some populations [48, 49]. However, 
this explanation cannot be easily extended to another population with very high levels 
of insulin resistance, South Asians, who are unlikely to have experienced 
colonization-induced famine on the scale hypothesized for Native Americans and 
Pacific Islanders. Instead, it is possible that general undernutrition could have resulted 
in selection for individuals with ‘thrifty genes’ across many human populations. 
Comprehensive data for interpopulation differences are not available, but on current 
evidence it seems probable that Western Europeans, who are frequently used as a 
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reference in cross-population studies of insulin resistance and associated disorders, 
have unusually low levels of insulin resistance compared to most other human groups 
[50, 51]. This implies that they are better adapted than many human groups to the 
‘Westernized’ diets and lifestyles now being adopted worldwide, although it is not 
clear whether this adaptation occurred recently and relatively rapidly [51] or much 
earlier [50].   
 
If an evolutionary basis to conditions of insulin resistance is assumed, it is possible 
that adaptation to seasonality, rather than to more extended, migration-induced 
feast/famine periods, accounts for the high levels of PCOS evident in many 
populations. Much of human evolution occurred in seasonal environments, and 
seasonal fluctuations have the potential to be important selective pressures [52]. 
Seasonality has a profound effect on human biology and health, and has been 
correlated with changes in the incidences of a range of conditions including infectious 
disease, peptic ulcer, asthma, stroke and congenital anomalies [53]. Seasonal 
variations in fertility, birth and reproductive performance have also been observed 
[54, 55]. The term ‘seasonality’ covers a range of phenomena, including photoperiod, 
climate and resource availability, and it is possible that some or all of these factors 
contribute to differential fertility and reproduction [54, 55]. However, there appears to 
be a particularly close link between negative energy balance and lowered birth rates 
[55]. In these circumstances, birth rates might be suppressed through physiological 
responses to undernutrition that result in anovulation [55, 56]. In women with PCOS, 
however, the weight loss that accompanies a reduced energy intake, even if it is 
relatively modest, may well facilitate rather than impair ovulation, allowing them to 
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conceive at times when other women are less likely to. This could constitute a ‘food 
deprivation hypothesis’.  
 
The transition between anovulation and ovulation might occur quite quickly in times 
of seasonal food shortage, as caloric reduction can lead to relatively rapid weight loss. 
In obese native Hawaiians, replacement of a Westernised diet by a traditional, 
relatively low calorie (1600 kCal), low fat diet led to an average weight loss of 7.8 kg 
over three weeks, equating to a BMI reduction of 2.6 kg/m
2
 [57]. In obese subjects 
under severely restricted caloric regimens (between 400 – 800 kCal/day), weight 
losses of between 1.4 and 2.5 kg per week have been observed in both males and 
females, leading in some cases to a weight loss of nearly 15kg over six weeks [58]. 
Clinical studies of the impacts of weight loss on fertility have also demonstrated that 
pregnancy can occur reasonably soon after starting controlled diet and exercise 
programmes. In a study of obese infertile women on such a programme (around 80% 
of whom had PCOS), the mean weight loss was 10.2 kg, the vast majority resumed 
spontaneous ovulation within six months, and nearly 30% of the total sample also 
achieved a medically unassisted pregnancy in that time [59]. Although this study was 
undertaken over a six month period, other research has shown that the metabolic 
profile of women with PCOS can improve within four to eight weeks of starting a diet 
and exercise programme [60], and ovulation can occur on the loss of approximately 
5.5 to 6.5 kg or 2 – 5% of previous body mass (as reviewed by [61]). In some 
populations, weight loss in women during the ‘hungry’ season can be as much as 5 
kg, although modal values appear to be closer to 2 – 3 kg (reviewed in [55, 62]). 
Interestingly, greater weight loss has been seen in women with higher BMIs than in 
those who are more lean [62]. Women with PCOS living in traditional subsistence 
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societies are unlikely to reach the levels of obesity observed in developed or rapidly 
developing populations, but they might well have raised BMIs compared to other 
women in the same community. Further work is required to assess the prevalence and 
presentation of PCOS in such populations, as well as the phenotype of women with 
the condition. However, extrapolation from observations on general responses to 
seasonality indicate that it would be very possible for anovulatory women with PCOS 
living in environments with seasonal fluctuation in resource availability to lose 
sufficient weight to ovulate then conceive.  
 
Conception during the ‘hungry’ season could have advantages and disadvantages for 
mother and child. In rural Gambia, infants conceived in the wet season, at the time 
when fertility is lowest, appeared to have lower mortality rates than those conceived 
at other times [55]. If this holds for other populations, and if women with PCOS are 
most likely to conceive when the fertility of other women is reduced, there is 
potentially an immediate fitness benefit associated with PCOS. By conceiving at the 
time of greatest food shortage, it is probable that at the most energetically-expensive 
time in pregnancy, the third trimester [63], there will be a reasonable supply of food, 
even though the most abundant period occurred in early pregnancy. In the Gambia, 
infants of mothers whose third trimester coincided with the wet season had lower 
birthweights, a risk factor for infant mortality [55], again highlighting the potential 
advantages of conceiving during the wet season. However, this birth timing may be 
disadvantageous in terms of lactation and subsequent growth into adulthood, with 
evidence from the Gambia tentatively indicating that females born in the dry season 
(between April and August) grow into lighter and smaller adults [64].  
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The ‘food deprivation hypothesis’ presented here relies on seasonal food shortage and 
consequent weight loss. However, it is likely that in many societies, food reserves are 
carefully managed in order to prevent severe and dramatic food shortages. Such 
behaviour may significantly reduce the period of time in which energy intake is well 
below energy expenditure, and in turn decrease any selective advantage of conception 
during this time. Clearly, in-depth, systematic studies are required to adequately test 
whether there are links between seasonality and PCOS. One alternative that 
nonetheless draws on food deprivation is that PCOS is an adaptation to climatic 
‘unpredictability’. In areas of the world with high reported levels of PCOS, including 
the Indian subcontinent, parts of the Americas and Australia, indigenous populations 
are faced with frequent climatic unpredictability, such as drought, failure of 
monsoons, hurricanes, cyclones and El Niño effects. All of these can lead to severe 
food shortages, which in turn might impact, through the mechanisms discussed briefly 
above, on fertility in women with and without PCOS. Indeed, famine can have a 
major impact upon the fertility of a population [65], and those caused in the past by 
climatic events are likely to have been frequent and severe enough to act as selective 
pressures on humans, with one possible result being the emergence of high levels of 
PCOS. In addition to maintaining the population during these periods of extreme food 
shortage, babies born to mothers with a tendency towards insulin resistance might 
have a greater ability to survive famine periods. Women with gestational diabetes 
tend to have babies who are of above average weight at birth [66]. In one population 
with high levels of insulin resistance, South Asians, infants have a tendency to have 
low body weights but have a high proportion of adipose tissue [67]. Infant mortality is 
a common and significant result of famine [68, 69], so if babies are able to ‘buffer’ 
themselves through either a larger body mass or greater adiposity laid down during 
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gestation, they may have a better chance of survival. Again, the role of unpredictable 
climate and resulting food deprivation as a selective pressure for PCOS requires 
further, systematic testing, but on current evidence, it cannot be discounted that PCOS 
is adaptive in environments with fluctuating or unpredictable resources. 
 
This notwithstanding, conception during periods of hunger seems paradoxical. It may 
be important to distinguish here between famine and chronic malnutrition, as the 
physiological mechanisms that regulate fertility in each of these situations differ. 
Famine may result in starvation amenorrhoea, in which ovulation ceases entirely as a 
result of either extremely low energy intake or turnover [70]. Under conditions of 
chronic malnutrition, however, conception is usually still possible but fertility is 
managed in other ways, such as through an increase in the length of time before 
postpartum resumption of ovarian function [70], which influences birth spacing. Thus, 
one question is whether having a PCOS phenotype is advantageous not in 
environments characterised by chronic malnutrition but in conditions that precipitate 
starvation anovulation. In times of constant plenty, follicular recruitment in women 
with PCOS is excessive. The FSH drive cannot mature such a high number and they 
arrest at about 5cm diameter. The total surface area of granulosa provides oestrogen 
feedback to the pituitary which produces LH, resulting in the characteristic hormone 
profile of PCOS. Weight loss in women with obese polycystic anovulation often 
results in ovulation, so in famine situations these phenotypes may be the first to 
recruit follicles in response to improving nutrition. Thus it is not starvation that 
stimulates ovulation in this alternative ‘re-feeding hypothesis’, but the return of food.  
 
 15 
A third possibility is a ‘trans-generational privation hypothesis’. If a population 
suffers persistent, severe, yet subfatal, privation (chronic malnutrition), it would be 
beneficial to have an enhanced androgenic and hence anabolic state that increases the 
efficient use of food for protein synthesis or fat storage. Clearly, females would have 
greater vulnerability than males, so those women with higher endogenous androgens 
might be better off. Such advantages would act directly, via nutrition (as described 
above) and also indirectly, as their female offspring would tend towards a preferred 
anabolic state. This is supported by the observation that prenatally androgenised 
laboratory macaques develop PCOS-like traits [44]. Moreover these offspring would 
possess the characteristic of preferred early ovulation, outlined in the ‘re-feeding 
hypothesis’. However, in environments with limited resources, it must also be 
considered that emotional stress might interact not only with reproduction but also 
with the creation of androgenic states in adult women and their female offspring. 
Food deprivation is inherently emotional stressful, and the effects of stress might 
reinforce in- or sub-fertility [71]. Stress has also been shown to influence metabolic 
abnormalities in adults with metabolic syndrome [72]. Importantly, stressful 
situations, including those caused by undernutrition, can lead to increased cortisol 
stimulation in neonates, encouraging rapid increases in body weight which may 
eventually result in pre- and post-pubertal hyperandrogenism and hyperinsulinemia 
and an increased probability of PCOS [72]. These observations draw attention to the 
proximate factors that could contribute, either on their own or in combination with 
genetic adaptations, to the prevalence of PCOS in certain populations.    
 
A limitation of evolutionary medicine is often the lack of testable hypotheses. Thus, it 
would be particularly interesting to compare the incidence of PCOS in populations 
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who have experienced recurrent famine with those that have not, or groups that have 
marked seasonal privation with those that have very little variation. Seasonal energy 
stress appears to have the greatest impact in India and parts of sub Saharan Africa 
[62], so it might be expected that if PCOS is an adaptation to seasonality, the 
prevalence would be highest in populations from these areas. South Asians certainly 
show very high levels of polycystic ovaries [15] and PCOS [4], although as the 
subcontinent has considerable geographic differences in the intensity of seasonal 
stresses, more detailed examination of the prevalence of PCOS in different regions 
would be advantageous, especially if viewed in the context of past population 
movements. Data on indigenous African populations are scarce. One of the few, albeit 
non-random, studies of polycystic ovaries in African women found that the 
prevalence of polycystic ovaries was high in infertile Yoruba women [16], although 
no endocrine data were reported. The Yoruba traditionally inhabit east Benin and 
western Nigeria, a region that Ferro-Luzzi & Branca [62, p. 161] label as having low 
to moderate seasonality. If these women are also found to have the associated 
metabolic syndrome, this observation does not necessarily support the general 
hypothesis that polycystic ovaries are an adaptive response to extreme seasonal 
resource fluctuation. Outside Africa, high levels of PCOS are reported in aboriginal 
Australians [20] and Mexican Americans [22]. Neither of these groups is usually 
thought to be under extreme seasonal resource stress, although it has been pointed out 
that traditional views of Aboriginal Australian subsistence might overestimate the 
resources available at certain times of the year and underestimate the effort expended 
in procuring them [73].  
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It is possible that the emergence of PCOS predated current population distributions or 
even modern humans themselves. It has been argued that due to the demands of 
‘growing’ large-brained fetuses, female primates require a suite of reproductive 
adaptations that predispose to ovulatory dysfunction similar to that seen in PCOS 
[74]. Thus, the origins of the condition (whether or not it has subsequently been 
advantageous in seasonal environments) might be relatively ancient. Similarly, 
because of steadily decreasing global temperatures and increasing aridity, seasonality 
is likely to have been a significant selective pressure as far back as the late Miocene 
and early Pliocene [52]. It is impossible to test whether PCOS existed in early 
hominins and if it could have conferred a benefit in the changing environments of the 
late Miocene, Pliocene and Pleistocene. However, whichever hypothesis is 
considered, primate models might shed some light on the evolutionary basis of the 
condition. Although prenatally androgenised laboratory macaques develop PCOS-like 
traits [44], to date there is no evidence for a similar syndrome in wild-living monkeys. 
Establishing whether ‘PCOS’ occurs spontaneously in non-human primates, and 
whether it is found in species such as baboons and macaques, and indeed other 
mamals, that evolved and currently live in seasonal environments, would provide an 
important comparative perspective on the condition in modern humans and potentially 
their ancestors.    
 
5.5 Why Is PCOS Not At Even Higher Levels In Modern Populations?  
 
Regardless of the circumstances under which high levels of PCOS evolved, it is 
plausible that PCOS gives reproductive benefits in environments with fluctuating 
resources. Women with PCOS, who generally have high androgen levels, also appear 
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to have greater bone mineral density [75] and muscle mass [45] than non-PCOS 
women. This might provide additional advantages in terms of greater capacity for 
physical work and endurance [45], which may be especially desirable in regions 
where subsistence requires considerable energy expenditure. Given these possible 
benefits, an obvious question is why PCOS is not found at even higher levels. One 
controversial explanation is that since direct evidence of fertility and potential 
fecundity in human females is concealed, morphological features associated with 
reproduction, such as fat patterning, might be very important in mate choice and 
perceived attractiveness [76], and therefore reproductive success. Many women with 
PCOS, even when they are non-obese, exhibit fat patterning that is most commonly 
seen in males, and it has been argued that as a result of this, they might be less 
attractive to potential mates [76]. However, this argument is weakened considerably 
by the simple observation that there is likely to be a strong genetic element to PCOS 
and that women with the condition do reproduce. More probable is that although 
PCOS confers an advantage at certain times, it is disadvantageous at other times, 
when food is more readily available. The total reproductive window is therefore 
reduced for women with PCOS. Alternatively, it is possible that as food supplies 
become increasingly buffered against seasonal or climatic fluctuations, the 
polymorphism has moved from being balanced to transient, with the deleterious 
effects of PCOS outweighing the advantages, leading to selection against individuals 
with a genetic predisposition to PCOS. Under this model, it is possible, for example, 
that the prevalence of PCOS in European countries was at higher levels in the past, as 
has been hypothesised for type 2 diabetes [51].  
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5.6 Critical Analysis Of The Evolutionary Perspective On PCOS 
 
The notion that PCOS is a manifestation of the selective pressures in our evolutionary 
past is an attractive one. However, despite having over forty years to test Neel’s  
original ‘thrifty genotype’ hypothesis [48], formulated to account for type 2 diabetes 
rather than PCOS, the search for candidate ‘thrifty’ genes has been problematic and 
no consensus has yet been reached about the validity of the concept [77; see also 
Chapter 4]. Particular criticism has come from proponents of the ‘thrifty phenotype’ 
hypothesis, who argue for a strong developmental, rather than genetic, basis to insulin 
resistance [42]. However, the ‘thrifty phenotype’ is not without major limitations, not 
least the lack of solid evidence found to date, the uncritical use of birthweight as an 
indicator of fetal growth restriction, and the need for more sophisticated studies to 
elucidate patterns and mechanisms [78]. Barker [79, p. 250] argued that, under the 
thrifty genotype hypothesis, high levels of type 2 diabetes would be evident in south 
Asian populations until a more ‘primitive’ way of life was adopted once more, 
reasoning that could presumably be extended to PCOS. However, recent ‘consensus’ 
work on insulin resistance and associated conditions, including PCOS, indicates that 
there is an underlying genetic component which is ‘primed’ by proximate influences, 
some of the most important of which may well occur during fetal or early life [28]. 
This suggests that elements of ‘thrifty genotype’ and ‘thrifty phenotype’ are not 
mutually exclusive. In addition, by removing the selective pressure of uncertain food 
supplies, under an evolutionary model the PCOS polymorphism may be expected to 
move over time into a transient state, as the genes that predispose to conditions of 
insulin resistance are selected against.  
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This notwithstanding, one major theoretical problem with the thrifty genotype 
hypothesis as it is often presented for PCOS is the need to invoke group selection to 
explain one of the major advantages of the condition. The idea that women with 
PCOS are able to ‘rescue’ the population in times of energy shortage through losing 
weight, ovulating and subsequently conceiving, stresses the benefits to the group but 
not to the individual. Although group selection might well be more important in 
human evolution than is currently acknowledged [80], it remains an unpopular 
concept in evolutionary biology, partly due to the popularity of ‘selfish gene’ models 
and also because it is rarely or never observed in ‘real’ populations [81]. However, the 
hypothesis does not stand or fall on the validity of group selection. There might be 
fitness benefits to the individual in conceiving at a time when other women do not, as 
infant mortality might be lower, at least in some populations [55]. Interestingly, and 
adding weight to this, Bangladeshi babies who survived the 1974-1975 famine had 
significantly lower mortality in the months following the famine than would normally 
be expected for those age cohorts, suggesting that selection had taken place [68]. 
Thus, although the advantages to the group might be tangible and important, 
advantages to the individual are also possible under the PCOS thrifty genotype 
hypothesis.  
 
In the context of evolutionary medicine, there is still much work to be done to test the 
thrifty genotype hypothesis, especially for PCOS. The three hypotheses presented in 
this chapter require more data than are currently available in order to support or refute 
them. Given sufficient resources, it should be possible to examine links between 
seasonality and PCOS, as populations which live under extreme seasonal pressures 
still exist, as do those that have few seasonal pressures. One potential region for future 
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study is the highly seasonal Gambia, where decades of research into maternal health 
have already been undertaken. One further challenge within this framework would be 
assessing whether it is the ‘re-feeding’ element that is crucial for restoration of 
fertility. It may be harder to test whether climatic unpredictability has influenced 
PCOS prevalence, as it not only requires knowledge of current climatic activity and 
its interaction with food supply but also needs accurate reconstruction of past climates 
and subsistence practises. The same is true of the ‘trans-generation privation 
hypothesis’. This issue goes to the heart of the limitation of evolutionary medicine: 
that much selection has occurred in periods for which there are little or no accurate 
data, and under population regimes that can, at best, only be approximated.   
 
5.7 Do Evolutionary Hypotheses Relating To PCOS Aid Clinical Practice? 
 
The wealth of research into PCOS that has been undertaken in the past decade has 
shed much light on the causes and treatment of PCOS, particularly in the context of  
infertility. The recognition that polycystic ovaries and the related syndrome are highly 
prevalent has led a number of authors to suggest an evolutionary basis for PCOS [7, 
45 – 47], and although the hypotheses require much more rigorous testing, the 
underlying idea is plausible, especially in the context of fluctuations in resource 
availability caused by either seasonal stresses or climatic unpredictability. However, 
diseases and medical conditions can have proximate and ultimate causes, and focusing 
on the evolutionary background to a condition may not necessarily lead to the most 
effective treatment and management of it.  
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Given that PCOS is argued to be adaptive in environments in which there are periods 
of extreme and sometimes rapidly-occurring food shortage, and that weight loss 
appears to trigger ovulation in many women with the syndrome, ‘crash’ dieting could 
be seen by some as a useful and relatively easy way of restoring fertility. Removed 
from the context in which PCOS evolved, however, this strategy is likely to produce a 
harmful cycle of ‘yo-yo’ weight loss and gain, which may result in  increased BMI 
and possibly harmful metabolic complications [82]. Instead, endocrinologists 
managing conditions of insulin resistance recommend long-term lifestyle modification 
that is sustainable and achievable [60]. Overemphasising the possible evolutionary 
basis of PCOS might conversely lead women with the syndrome and their healthcare 
providers to adopt a fatalistic attitude towards its management. Concern has been 
raised about ‘genetic determinism’ in clinical treatment for the related condition, type 
2 diabetes, especially with respect to marginalised and deprived Native American 
groups [77, 83]. There is the potential for this to occur in the context of PCOS, for 
example in South Asian women living in Europe and North America. South Asian 
women exhibit a higher prevalence of PCOS than is found in the general Western 
population [4], but, like other immigrant populations, they may have difficulty in 
accessing necessary healthcare [84]. Such barriers, whether they be socioeconomic, 
linguistic or cultural, could be reinforced by stressing the possible evolutionary basis 
to the syndrome and creating the illusion that it is not worth seeking treatment 
because PCOS is inevitable in South Asian women.  
 
Nonetheless, a recognition that individuals who have a genetic predisposition to the 
disease can have their risk reduced through prevention of maternal malnutrition might 
be a useful public health strategy. This type of approach recognises the 
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genetic/evolutionary backdrop to the condition whilst seeking to control the proximate 
environmental influences that influence the development and severity of the 
condition. However, even the adoption of this approach is far from straightforward. 
Maternal size acts as a constraint on fetal size, and nutritional intervention in 
pregnancy may in fact lead to an increased rather than decreased risk of insulin 
resistance in the offspring, due to the so-called ‘thin-fat baby’ phenomenon [78]. This 
might be especially marked in South Asian infants, who have a tendency to have less 
muscle mass and greater fat mass – the ‘thin fat baby’, a body composition that 
predisposes to insulin resistance [67, 85]. Thus, improvement in intergenerational 
nutrition might well be necessary to seriously address insulin resistance [78], a 
management option that might also be useful in tackling PCOS.    
 
Such are the possibly negative impacts of evolutionary hypotheses in PCOS. On the 
positive side, comprehension of the origins of diseases can be highly beneficial to 
patients. Contrary to the ‘crash diet’ risk is the belief by PCOS sufferers that they are 
“fat because they have PCOS” and that if the disease is treated then they will be thin. 
It has already been mentioned that the first line treatment for PCOS is weight loss. If 
the patient attends with the feeling that they will get a cure and thereby become thin 
they will react poorly to the advice they are given. With a sympathetic explanation 
that in another time their efficient use of food, a scarce commodity, would have made 
them the first to conceive, there may be less stigma and a more constructive 
acceptance of  their need to reach an optimal BMI. Crash dieting is not recommended; 
it is not suggested here, after all, only that famine improves fertility in women with 
PCOS. Another arm to the ideas presented in this chapter is that reintroduction of 
food following a famine-induced anovulation initiates follicular recruitment. So, 
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careful explanation of this to the patient could emphasise exercise as the more helpful 
part of lifestyle change over and above diet. 
 
A positive and long term benefit to evolutionary understanding is as a guide to future 
research, both medical and anthropological. If there is a strong belief that this is a 
genetically driven disease, then continued search for the genes concerned might lead 
to a more fundamental treatment than exists at the moment. If not actual gene therapy, 
it may be that the source protein might hold the key to future treatment developments. 
However, what is, or what are, the gene(s)? Where are they located? Do the 
responsible genes code for insulin resistance, lipid metabolism, follicular recruitment 
sensitivity, or do they work at the level of the switch for rendering follicles atretic (i.e. 
as part of the maturation and degeneration process)? Understanding the evolution of 
the disease helps in the search for the answers to these questions. From the answers 
will come future treatments. 
 
5.8 Conclusions 
 
PCOS is a nebulous and complex endocrine condition. This is reflected by the fact 
that its definition has changed frequently during the second half of the 20
th
 century. 
Currently, possession of two characteristics is required from a list of recognised 
features in order to make the diagnosis. Its familial nature, the level of twin 
concordance and variation in different populations lend weight to a genetic basis to 
this condition. However it is accepted that gene expression is subject to environmental 
influence, including during fetal or early life. The syndrome links reproductive 
performance with nutrition in the form of glucose and lipid metabolism, factors at the 
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heart of survival. If genetics are at the core of such a common condition, the question 
of whether there is an evolutionary advantage to the possession of the gene or genes is 
inevitably raised.  
 
Three hypotheses have been proposed in this chapter. The first concerns the 
observation that PCOS sufferers tend to ovulate when weight is lost. Indeed, that 
forms the primary treatment of the condition. Perhaps there might be an advantage for 
members of a population to conceive during a food shortage. The observation in the 
Gambia of lower mortality amongst infants conceived in the wet season, a period of 
food deprivation, lends weight to this. This ‘food deprivation hypothesis’ sees a 
positive enhancement in ovulation when food is short and as such might suggest that 
the primary effect of the gene is related to glucose metabolism. The second hypothesis 
suggests that individuals with a PCOS-like condition living in a ‘traditional’ 
environment would not be as well fed, even in times of plenty, as they would in an 
industrialised environment. In this scenario, the advantage occurs at the end of a 
period of food deprivation as the food source increases. These women are the first to 
ovulate in response to this re-feeding. An anabolic propensity for food storage is an 
appropriate adjuvant preparation for early pregnancy. This ‘re-feeding hypothesis’ 
implies that the gene might be one that drives ovarian follicular recruitment sensitivity 
to FSH. The third hypothesis suggests that the origin of the gene may pre-date modern 
humans, possibly being related to the onset of seasonal environments in the late 
Miocene, or the climatic fluctuations that characterised Pleistocene environments. A 
beneficial strategy favouring insulin resistance might have improved survival at that 
time. This ‘trans-generational privation hypothesis’ again suggests a gene inducing 
insulin resistance. 
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Food deprivation lies at the heart of these hypotheses, as insulin resistance buffers the 
individual against food shortage. Although the advantages of insulin resistance are 
described elsewhere in relation to type 2 diabetes mellitus, it is likely to be at its most 
profound if associated with follicular recruitment. Significant pressure on food 
resources would have been needed to favour these genes. In the case of the ‘trans-
generational hypothesis’, the strategy might have been part of a wider suite of 
adaptations necessary to deal with long-term environmental change. In the case of the 
‘food deprivation’ and ‘re-feeding’ hypotheses, fluctuations in resource availability 
leading to food deprivation probably would be severe but frequent. Climatic 
unpredictability is one source of this, but the most regular occurrence of food 
deprivation is, of course, seasonality. Variability in the frequency of PCOS from 
population to population suggests that inhabiting seasonal environments might have 
contributed to selection for the PCOS genotype. Studies comparing PCOS in 
indigenous peoples from highly seasonal and  less seasonal areas might throw some 
light on this. As the diagnosis is so ill-defined, negative correlations might be less 
relevant than positive ones. 
 
One further question is whether the adaptation is primarily for nutritional survival 
with a reproductive add-on, or whether the opposite is true. Discovering where the 
genes are located and for which proteins they code would help to elucidate the 
evolution of PCOS and also aid patient education. Even if alterations in 
intergenerational maternal nutrition help to reduce the overall prevalence of the 
syndrome or severity of the symptoms, greater knowledge of the genetic and 
evolutionary basis to PCOS would guide future treatment strategies. Only within such 
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an approach does there lie a cure as opposed to the symptomatic treatment currently 
available. 
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 Population % prevalence Reference Notes 
P
C
O
 
General population (Western) 21-23% Sources cited in [5]  
British South Asian 52%  [15]  
P
C
O
S
 
General population (Western) 8% [5]  
European New Zealanders In proportion to general 
population 
[19]  
Maori New Zealanders In proportion to general 
population 
[19]  
Pacific Island New Zealanders In proportion to general 
population 
[19]  
Chinese New Zealanders Under-represented [19]  
Indian  New Zealanders Over-represented [19]  
Aboriginal Australians 26% [20] Preliminary data 
Mexican Americans 13% [22] Self-reported 
Greeks (Lesbos) 7% [18]  
   
Table 1: Prevalence of polycystic ovaries (PCO) and polycystic ovary syndome 
(PCOS) in different populations. Polycystic ovaries can be present without the 
associated syndrome. Current consensus on the diagnosis of polycystic ovary 
syndrome relies on the presence of at least two of the following in combination: 
identification of polycystic ovaries on ultrasound; oligo-/anovulation; biochemical 
evidence of androgen excess [5]. However, since the condition is nebulous, diagnoses 
have been made on the basis of other criteria, so the data reported here are not 
necessarily internally consistent or directly comparable.  
